Takamiya O
School of Allied Medical Science, Shinshu University, Matsumoto.
Rinsho Byori. 1991 Apr;39(4):437-41.
This paper introduces a newly developed enzyme-linked immunosorbent assay (ELISA) method, using monospecific anti-human factor VII rabbit IgG, to quantify antigen levels of factor VII. The procedure is relatively simple, its method is remarkably specific and reproducible. Its sensitivity to detect factor VII antigen is as low as 0.015 U/ml, when factor VII antigen in 1 ml normal plasma is arbitrarily defined as 1 unit. The level of factor VII antigen in 4 patients with congenital factor VII deficiency and their family members was investigated through this ELISA and the results correlated well with those obtained by electroimmunoassay previously described. The significant correlation between the antigen levels and activity of factor VII was demonstrated in 4 patients with congenital factor VII deficiency and their family members, normal individuals and patients with liver disease. However, the level of factor VII antigen in patients treated with warfarin was higher than their coagulation activity.
本文介绍了一种新开发的酶联免疫吸附测定(ELISA)方法,该方法使用单特异性抗人因子VII兔IgG来定量因子VII的抗原水平。该程序相对简单,其方法具有显著的特异性和可重复性。当将1 ml正常血浆中的因子VII抗原任意定义为1个单位时,其检测因子VII抗原的灵敏度低至0.015 U/ml。通过该ELISA法对4例先天性因子VII缺乏症患者及其家庭成员的因子VII抗原水平进行了研究,结果与先前描述的电免疫测定法所得结果相关性良好。在4例先天性因子VII缺乏症患者及其家庭成员、正常个体和肝病患者中,均证明了因子VII抗原水平与活性之间存在显著相关性。然而,接受华法林治疗的患者的因子VII抗原水平高于其凝血活性。